Ginsenoside Rh2 Attenuates Intervertebral Disc Degeneration by Modulating the PI3K/AKT Signaling Pathway to Suppress Apoptosis
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27188228 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Bo Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China. Hauptthemen laut MEDLINE: Ginsenosides, Intervertebral Disc Degeneration, Proto-Oncogene Proteins c-akt, Apoptosis. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Sailing Program, National Natural Science Foundation of China, Shanghai Science and Technology Commission.
Abstract (Originalsprache)
Intervertebral disc degeneration (IVDD) is a major cause of chronic low back pain and imposes a substantial socioeconomic burden. Ginsenoside Rh2 (Gin-Rh2), a bioactive ginseng compound with antioxidant properties, may have therapeutic potential in IVDD, but its effects and underlying mechanisms remain unclear. Here, we evaluated Gin-Rh2 in cellular and rat models of IVDD. In vitro, Gin-Rh2 attenuated interleukin-1β (IL-1β)-induced nucleus pulposus cell apoptosis, reduced matrix metalloproteinase-3 (MMP3) expression, and increased aggrecan and type II collagen production. Network pharmacology and molecular docking implicated the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathway as a potential target. Mechanistic experiments further indicated that inhibition of PI3K/AKT signaling contributed to the protective effects of Gin-Rh2, whereas pharmacological activation of this pathway partially attenuated these effects. In vivo, Gin-Rh2 attenuated puncture-induced disc degeneration. Collectively, these findings suggest that Gin-Rh2 protects nucleus pulposus cells and attenuates experimental IVDD, supporting its further investigation as a potential therapeutic candidate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Spine Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
ORCID-Profile: Qizhu Chen
Förderung
- Shanghai Sailing Program
- National Natural Science Foundation of China
- Shanghai Science and Technology Commission
- Xinhua Hospital
Zitieren
APA
Li, B., Chen, Q., Chen, Y., Zheng, H., Jin, L., Jiang, L., Zheng, X., & Jiang, S. (2026). Ginsenoside Rh2 Attenuates Intervertebral Disc Degeneration by Modulating the PI3K/AKT Signaling Pathway to Suppress Apoptosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188228
Vancouver
Li B, Chen Q, Chen Y, Zheng H, Jin L, Jiang L, et al. Ginsenoside Rh2 Attenuates Intervertebral Disc Degeneration by Modulating the PI3K/AKT Signaling Pathway to Suppress Apoptosis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188228
BibTeX
@article{Li2026,
author = {Li, Bo and Chen, Qizhu and Chen, Yichuan and Zheng, Huoliang and Jin, Linyu and Jiang, Leisheng and Zheng, Xingfeng and Jiang, Shengdan},
title = {Ginsenoside Rh2 Attenuates Intervertebral Disc Degeneration by Modulating the PI3K/AKT Signaling Pathway to Suppress Apoptosis},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27188228}
}
EUVIMED